News Reader
04-30-2009, 08:20 PM
Prompted by reports of serious adverse events, the U.S. Food and Drug Administration today announced that safety label changes, including a boxed warning, and a Risk Evaluation and Mitigation Strategy (REMS), are necessary for all botulinum toxin products.
More... (http://www.fda.gov/bbs/topics/NEWS/2009/NEW02005.html)
More... (http://www.fda.gov/bbs/topics/NEWS/2009/NEW02005.html)